Fred Hutchinson Cancer Research Center (FHCRC) is a clinical research site located in Seattle, Washington, United States 98109.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Fred Hutchinson Cancer Research Center (FHCRC) has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Scleroderma, Systemic, Sclerosis, Autoimmune Disease.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Geron Corporation, Massachusetts General Hospital.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Fred Hutchinson Cancer Research Center (FHCRC) has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fred Hutchinson Cancer Research Center (FHCRC) has 5 clinical trials on record, with 2 currently active. Their work covers Scleroderma, Systemic, Sclerosis, Autoimmune Disease.
Yes — Fred Hutchinson Cancer Research Center (FHCRC) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.